NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,072,843 | -34.7% | 160,222 | -7.1% | 0.02% | -43.3% |
| Q1 2023 | $6,236,272 | -1.1% | 172,511 | +8.4% | 0.03% | -28.6% |
| Q4 2022 | $6,304,716 | -99.9% | 159,210 | +43.4% | 0.04% | +2.4% |
| Q3 2022 | $5,174,790,000 | +10.7% | 111,047 | +4.2% | 0.04% | -2.4% |
| Q2 2022 | $4,673,198,000 | +11.3% | 106,621 | +83.6% | 0.04% | +23.5% |
| Q1 2022 | $4,200,564,000 | +992941.1% | 58,075 | +1513.2% | 0.03% | +1033.3% |
| Q4 2019 | $423,000 | -79.7% | 3,600 | -88.1% | 0.00% | -72.7% |
| Q4 2017 | $2,085,000 | -60.2% | 30,200 | -57.1% | 0.01% | -73.8% |
| Q2 2017 | $5,244,000 | -19.6% | 70,453 | +1.2% | 0.04% | -22.2% |
| Q1 2017 | $6,520,000 | +693.2% | 69,585 | +514.8% | 0.05% | +671.4% |
| Q4 2016 | $822,000 | -59.7% | 11,319 | -42.1% | 0.01% | -63.2% |
| Q3 2016 | $2,041,000 | – | 19,548 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |